![]() |
市场调查报告书
商品编码
1959903
自主手术机器人市场-全球产业规模、份额、趋势、机会、预测:按产品类型、应用、最终用户、地区和竞争对手划分,2021-2031年Autonomous Surgical Robotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End-User (Hospitals, Ambulatory Surgery Centers, Others), By Region & Competition, 2021-2031F |
||||||
全球自主手术机器人市场预计将从 2025 年的 22.3 亿美元大幅成长至 2031 年的 45.3 亿美元,复合年增长率达 12.54%。
该领域涵盖利用人工智慧进行术前策略制定和即时指导的智慧机器人平台,这些平台能够以不同程度的自主性执行手术任务。推动该领域成长的主要因素是需要手术治疗的慢性疾病的普遍存在,以及对能够加速患者康復的微创手术技术的强劲需求。此外,全球医疗专业人员短缺也促使人们采用自动化技术来提高手术精度。国际机器人联合会的数据也支持这一趋势,数据显示,到2024年,医疗机器人的销售将激增91%,达到约16,700台。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 22.3亿美元 |
| 市场规模:2031年 | 45.3亿美元 |
| 复合年增长率:2026-2031年 | 12.54% |
| 成长最快的细分市场 | 机器人系统 |
| 最大的市场 | 北美洲 |
然而,由于法规环境复杂且专注于问责制和安全,该市场面临许多障碍。随着系统朝自主决策方向发展,操作失误和不良病人后果的责任认定也引发了棘手的法律挑战。除了法规结构尚不明确之外,临床检验和认证所需的大量资金也严重阻碍了这些先进外科技术的广泛商业化和应用。
推动自主手术机器人普及应用的主要动力之一是熟练外科医生和医疗专业人员的严重短缺。随着专业医疗人员数量与需要复杂治疗的患者数量之间的差距日益扩大,医院正依靠机器人系统来补充人类的能力并简化工作流程。这些自动化平台将使更少的医生能够处理更多的病例,同时透过减轻操作者的体力负担和规范手术质量,在不影响安全性的前提下完成更多手术。根据美国医学院协会 (AAMC) 2024 年 3 月的报告,预计到 2036 年,美国将面临多达 19,900 名外科医生的缺口,这凸显了采用技术解决方案最大限度地提高手术能力的紧迫性。
同时,对微创手术技术的需求不断增长,正在重塑市场格局。随着患者和医疗机构寻求创伤最小、恢復更快的手术方式,机器人系统能够以比传统腹腔镜手术更高的精度完成这些精细手术,从而推动了其在泌尿系统、妇科和普通外科领域的应用。这种需求也体现在主要企业的快速成长。直觉外科公司(Intuitive Surgical)预计,到2024年底,其达文西手术在全球范围内将增长18%,这表明该技术在临床实践中得到了广泛认可。此外,新兴竞争对手也不断拓展其全球业务,CMR Surgica公司预计在2024年将迎来一个里程碑,其Versius系统在全球累积完成的手术数量将超过2万例。
全球自主手术机器人市场面临的主要限制阻碍因素是复杂的责任和安全保障监管环境。随着机器人系统朝向自主决策方向发展,现有的法律体制难以明确界定操作人员、医疗机构和设备製造商在发生不利事件时的责任。这种法律上的模糊性导致必须进行严格的安全检验和大规模临床试验,从而显着延长了产品开发週期。因此,製造商面临更长的监管核准时间、自主功能推出延迟以及阻碍投资的商业不确定性。
此外,满足这些严格标准带来的经济负担提高了创新开发商的进入门槛,阻碍了市场扩张。安全认证所需的大量资源往往会挤占技术研发资金,从而限制了产品改进的速度。据欧洲医疗技术协会(MedTech Europe)称,与先前的指令相比,到2024年,新法规结构下的认证和维修成本将增加高达100%。遵循成本的急剧上升降低了新业务的财务可行性,并减缓了自主技术在外科手术市场的整体普及速度。
将人工智慧 (AI) 应用于即时决策支援,正从根本上改变外科手术格局,将机器人系统转变为智慧的、数据驱动的合作伙伴。产业领导者正积极扩展其数位化生态系统,以整合机器学习演算法,从而实现术中导航、手术影片分析以及手术流程的即时优化。这项技术进步将能够预测关键解剖结构的识别并实现手术技术的标准化,从而显着降低患者预后的差异性。例如,美敦力公司于 2025 年 9 月宣布,已将其位于伦敦的数位化部门的员工人数增加了一倍,部署了 200 多名专家,以加速开发这些先进的人工智慧和数位化能力。
同时,单孔和多孔机器人平台的普及正在使市场多元化,以适应更广泛的临床适应症和医院环境。製造商正摒弃千篇一律的解决方案,转而推出专用系统,例如用于深部手术的单孔平台和专为复杂普通外科手术设计的高性能多孔系统。这种策略性细分使医疗机构能够采用与其病例特征精准匹配的技术,从而加速其在各个外科领域的应用。为了支持这一趋势,Intuitive Surgical 于 2025 年 1 月宣布,其在上年度中已在全球安装了 362 套新型「达文西 5」多孔系统。
The Global Autonomous Surgical Robotics Market is projected to expand significantly, rising from USD 2.23 Billion in 2025 to USD 4.53 Billion by 2031, reflecting a compound annual growth rate of 12.54%. This sector comprises intelligent robotic platforms that perform surgical tasks with varying levels of autonomy, leveraging artificial intelligence for both pre-operative strategy and real-time guidance. Growth is largely fueled by the prevalence of chronic conditions requiring surgery and a strong preference for minimally invasive techniques that speed up patient recovery. Additionally, the global scarcity of medical specialists is driving the uptake of automation to enhance surgical precision, a trend evidenced by International Federation of Robotics data showing a 91% surge in medical robot sales to nearly 16,700 units in 2024.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.23 Billion |
| Market Size 2031 | USD 4.53 Billion |
| CAGR 2026-2031 | 12.54% |
| Fastest Growing Segment | Robotic Systems |
| Largest Market | North America |
However, the market faces significant hurdles due to a complex regulatory environment focused on liability and safety assurance. As systems move toward autonomous decision-making, difficult legal questions arise regarding accountability for operational errors or adverse patient outcomes. These undefined regulatory frameworks, coupled with the immense financial resources needed for clinical validation and certification, create substantial obstacles to the widespread commercialization and adoption of these advanced surgical technologies.
Market Driver
A primary catalyst accelerating the deployment of autonomous surgical robotics is the critical shortage of skilled surgeons and healthcare personnel. As the gap widens between the supply of specialized professionals and the volume of patients requiring complex care, hospitals are relying on robotic systems to augment human capabilities and streamline workflows. These automated platforms reduce physical strain on operators and standardize procedure quality, allowing fewer surgeons to manage higher caseloads without compromising safety. According to a March 2024 report by the Association of American Medical Colleges, the United States is projected to face a shortfall of up to 19,900 surgeons by 2036, highlighting the urgent need for technological solutions that maximize surgical throughput.
Simultaneously, the rising preference for minimally invasive surgical techniques is reshaping the market, as patients and providers seek procedures that minimize trauma and accelerate recovery. Robotic systems facilitate these delicate operations with greater precision than manual laparoscopy, driving widespread adoption across urology, gynecology, and general surgery. This demand is reflected in the rapid growth of major industry players; Intuitive Surgical recorded an 18% increase in worldwide da Vinci procedure volume in late 2024, signaling robust clinical acceptance. Furthermore, emerging competitors are expanding their global footprint, with CMR Surgical celebrating a milestone of over 20,000 surgical cases completed globally using its Versius system in 2024.
Market Challenge
The complex regulatory landscape regarding liability and safety assurance acts as a major constraint on the Global Autonomous Surgical Robotics Market. As robotic systems evolve toward autonomous decision-making, existing legal frameworks struggle to clearly define accountability among human operators, medical institutions, and equipment manufacturers during adverse events. This legal ambiguity necessitates rigorous safety validation and extensive clinical trials, which significantly prolong the product development lifecycle. Consequently, manufacturers face extended timelines for regulatory approval, delaying the introduction of autonomous capabilities and creating operational uncertainty that deters investment.
Moreover, the financial burden associated with meeting these stringent standards hampers market expansion by raising barriers to entry for innovative developers. The substantial resources required for safety certification often divert capital away from technical research, limiting the speed of product iteration. According to MedTech Europe, certification and maintenance costs under the new regulatory framework escalated by up to 100% in 2024 compared to previous directives. This sharp increase in compliance expenditures reduces the financial viability of new ventures and slows the overall penetration of autonomous technologies in the surgical market.
Market Trends
The integration of Artificial Intelligence for real-time decision support is fundamentally altering the surgical landscape by transforming robotic systems into intelligent, data-driven partners. Industry leaders are aggressively expanding their digital ecosystems to embed machine learning algorithms that provide intraoperative guidance, analyze surgical video, and optimize procedural workflows in real-time. This technological evolution allows for the predictive identification of critical anatomy and the standardization of surgical techniques, significantly reducing variability in patient outcomes. For instance, Medtronic announced in September 2025 that it had doubled its London-based digital workforce to over 200 specialists specifically to accelerate the development of these advanced AI and digital capabilities.
Concurrently, the proliferation of single-port and multi-port robotic platforms is diversifying the market to address a wider range of clinical indications and hospital environments. Manufacturers are moving beyond one-size-fits-all solutions by launching specialized systems, such as single-port platforms for deep-access surgery and high-performance multi-port systems designed for complex general procedures. This strategic segmentation enables healthcare facilities to adopt technology that precisely matches their case mix, driving broader utilization across various surgical disciplines. Validating this trend, Intuitive Surgical reported in January 2025 that it successfully placed 362 units of its new da Vinci 5 multiport system globally during the previous year.
Report Scope
In this report, the Global Autonomous Surgical Robotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Autonomous Surgical Robotics Market.
Global Autonomous Surgical Robotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: